Translating pharmacogenetics to primary care
Swen, J.J.
Citation
Swen, J. J. (2011, December 21). Translating pharmacogenetics to primary care. Retrieved from https://hdl.handle.net/1887/18263
Version: Corrected Publisher’s Version
License: Licence agreement concerning inclusion of doctoral thesis in the Institutional Repository of the University of Leiden
Downloaded from: https://hdl.handle.net/1887/18263
Curriculum Vitae
207 Joachim Jesse Swen was born in Alkmaar, The Netherlands on March 5
th1978. After finishing secondary school (VWO) at the Han Fortmann College in Heerhugowaard in 1996, he started his study Pharmacy at the Utrecht University. In 2002 he obtained his doctoral exam, followed by his PharmD exam, in 2004. As part of his doctoral program he worked for nine months on a research project aimed at the development of a model to predict the lymphatic drug transport of testosterone esters. This work was performed at the Department of Pharmaceutics of NV Organon in Oss (supervisors Prof. dr. H.
Vromans, Dr. W.A. Faassen). From May 2004 to January 2006, he was involved in the implementation of PeopleSoft ERP software in the Department of Clinical Pharmacy
& Toxicology of the Leiden University Medical Center. In 2006 he started his training as clinical pharmacist which was completed in September 2011 (supervisor Prof. dr.
H-J Guchelaar). At the same time he started working on the studies presented in this PhD thesis (supervisors Prof. dr. H-J Guchelaar, Prof. dr. W.J.J. Assendelft, Dr. J.A.M.
Wessels). As part of his PhD project he joined the Helix group at the Department of Genetics, Stanford University, Palo Alto, CA, USA, for a period of three months in the fall of 2011 (supervisor Prof. dr. R. Altman). After completion of his PhD project he will continue his career as clinical researcher / pharmacist in the field of pharmacogenetics at the Leiden University Medical Center.
Jesse Swen lives in Amsterdam and is married to Charlotte Gubbels.
curriculumvitae
List of Publications
THIS THESIS
Swen JJ, Huizinga TW, Gelderblom H et al. Translating pharmacogenomics: challenges on the road to the clinic. PLoS Med 2007;4(8):e209.
Swen JJ, Wilting I, de Goede AL et al. Pharmacogenetics: from bench to byte. Clin Pharmacol Ther 2008;83(5):781-787.
Van der Straaten T, Swen J, Baak-Pablo R, Guchelaar HJ. Use of plasmid-derived external quality control samples in pharmacogenetic testing. Pharmacogenomics 2008;9(9):1261- 1266.
Swen JJ, Wessels JA, Krabben A, Assendelft WJ, Guchelaar HJ. Effect of CYP2C9 polymorphisms on prescribed dose and time-to-stable dose of sulfonylureas in primary care patients with Type 2 diabetes mellitus. Pharmacogenomics 2010;11(11):1517-1523.
Swen JJ, Nijenhuis M, de Boer A et al. Pharmacogenetics: from bench to byte- an update of guidelines. Clin Pharmacol Ther 2011;89(5):662-673.
Swen JJ, Guchelaar HJ, Baak-Pablo RF, Assendelft WJ, Wessels JA. Genetic risk factors for type 2 diabetes mellitus and response to sulfonylurea treatment. Pharmacogenet Genomics 2011;21(8):461-468.
Swen JJ, Van der Straaten T, Wessels JA et al. Feasibility of pharmacy initiated pharma- cogenetic screening for CYP2D6 and CYP2C19. Eur J Clin Pharmacol (in press).
Swen JJ, Baak-Pablo RF, Guchelaar H-J, van der Straaten T. Alternative methods to a Taq- Man assay to detect a tri-allelic SNP in the HNF1B gene. Clin Chem Lab Med (in press).
RELATED TO THIS THESIS
Swen JJ, Wessels JA, Guchelaar HJ. Farmacogenetica: van abstract begrip naar klinische praktijk. Geneesmiddelenbulletin 2010;44(9):97-103 (article in Dutch).
Wilffert B, Swen J, Mulder H et al. From evidence based medicine to mechanism based medicine. Reviewing the role of pharmacogenetics. Int J Clin Pharm 2011;33(1):3-9.
Swen JJ, Guchelaar HJ. Comment: global formulary review: how do we integrate phar- macogenomic information? Ann Pharmacother 2011;45(7-8):1030.
Opdam FL, Swen JJ, Wessels JA, Gelderblom H. Letter: SNPs and Haplotypes in DPYD and Outcome of Capecitabine. Clin Cancer Res 2011;17(17):5833-4
Swen JJ, Guchelaar HJ. Pharmacogenetic dose recommendations in clinical practice.
EJHP (in press).
211 OTHER
Van der Molen H, de Raadt W, Swen JJ. Van specifiek naar algemeen. ERP in het LUMC.
ICTzorg 2007;2(8):10-12 (article in Dutch).
Swen JJ, Krens L, Ten Brink MH. Een uur leven kost maximaal 9 euro 13. NRC Next 2010 February 15, Opinion section: 18-19 (article in Dutch).
Nijkeuter M, Huidekoper AL, Swen JJ. An autointoxication with nutmeg. Wetenschap- pelijk Platform Pharmaceutisch Weekblad 2011;4(5):65-67 (article in Dutch).
listofpublications